Page last updated: 2024-10-29

ketoconazole and Hepatic Failure

ketoconazole has been researched along with Hepatic Failure in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"A patient is reported who developed fatal liver failure on ketoconazole treatment for Cushing's syndrome."7.71Fatal liver failure due to ketoconazole treatment of a girl with Cushing's syndrome. ( Bonnici, F; Delport, S; Zöllner, E, 2001)
"A patient is reported who developed fatal liver failure on ketoconazole treatment for Cushing's syndrome."3.71Fatal liver failure due to ketoconazole treatment of a girl with Cushing's syndrome. ( Bonnici, F; Delport, S; Zöllner, E, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zöllner, E1
Delport, S1
Bonnici, F1

Other Studies

1 other study available for ketoconazole and Hepatic Failure

ArticleYear
Fatal liver failure due to ketoconazole treatment of a girl with Cushing's syndrome.
    Journal of pediatric endocrinology & metabolism : JPEM, 2001, Volume: 14, Issue:3

    Topics: Adolescent; Cushing Syndrome; Fatal Outcome; Female; Humans; Ketoconazole; Liver Failure; Liver Func

2001